Results: REL, RNRL, Biocon, Indiabulls, IDBI, Ranbaxy etc

Reliance Energy Q3 net profit up 50%
Rel Energy Q3 net profit up at Rs 301.6 cr
17th-Jan-2008

Reliance Energy announced its Q3 net profit. The company in Q3 reported standalone net profit of Rs 301.60 crore versus Rs 201.03 crore on YoY basis.

----------------------------------------------------------
Biocon Oct-Dec net profit up 500% YoY
Biocon Q3 cons net profit at Rs 291.83 cr view table
17th-Jan-2008

Biocon has announced its third quarter numbers. It has posted consolidated net profit of Rs 291.83 crore for the quarter ended December 2007 as against Rs 55.31 crore in same quarter of previous year. Other income is included in net profit.
-------------------------------------------------------------
Indiabulls Financial Q3 consolidated net jump 80% (Update)
Indiabulls Fin Q3 net profit up at Rs 246.4 cr view table
17th-Jan-2008

Indiabulls Financial services announced its Q3 FY08 result. Before demerger, its Q3 FY08 consolidated net profit was up at Rs 246.4 crore versus Rs 111.8 crore on YoY basis. During the same quarters, its consolidated net sales were up at Rs 661.3 crore.

Indiabulls Financial Services announced today (Thursday) the consolidated profit after tax jumped 80.31% to Rs 1,639 million in Q3 of FY 08 from Rs 909 million in Q3 of FY 07 and consolidated total revenues went up 98.1% to Rs 4,535 million in Q3 of FY08 from Rs 2,289 million in Q3 of FY 07, considering the demerger of Indiabulls (Q, N,C,F)* Securities.On sequential basis, the consolidated profits after tax up 47% to Rs 1,639 million in Q3 FY 08 from Rs 1,115 million in Q2 FY 08 and consolidated total revenues climbed 29.39% to Rs 4,535 million in Q3 FY 08 from Rs 3,505 million in Q2 FY 08.

-----------------------------------------------------------
IDBI Q3 net profit jumps 39%
IDBI Q3 standalone net profit up at Rs 175.84 cr view table
17th-Jan-2008

IDBI has declared its third quarter numbers. It has posted standalone net profit of Rs 175.84 crore for the quarter ended December 2007 as against Rs 126.79 crore in same period of previous year.
------------------------------------------------------------
RNRL Q3 net profit up over 127 per cent
RNRL Q3 net profit up at Rs 23.79 cr view table
17th-Jan-2008

RNRL has declared its third quarter results. Its Q3 standalone net profit stood at Rs 23.79 crore versus Rs 10.45 crore, YoY.
------------------------------------------------------------
Ranbaxy Q4 net slips 65.20% on lower margins
India`s largest pharmaceutical company, Ranbaxy Laboratories announced today the substantial rise of 53% in net profit to Rs 7,901 million in FY07, compared with previous year. Excluding foreign exchange gains / losses on translation and extraordinary items, net profit for the year was at Rs 6,069 million, reflecting a rise of 15%, the company said. Earnings per share on a fully diluted basis were at Rs 15.30 in FY07, reflecting a rise of 16.17% over FY06. For the year, the company recorded sales of Rs 66,353 million, registering a growth of 9% over FY06.Speaking on the occasion, Malvinder Mohan Singh, CEO and MD, RanbaxyLaboratories, (Q, N,C,F)* said, ``The results for the year 2007 are per our expectations. This is on the back of strong growth in our emerging markets, a significant growth of business in Europe and a strong performance in our US branded business. We have also taken appropriate steps to structure the business for the future by forming alliances in several niche therapeutic areas, enhanced product visibility and brought in certainty of profit flow for the future. I believe the coming years will see Ranbaxy emerge stronger and better positioned to achieve its goal of becoming a top five global generics company.``Q4 FY07Ranbaxy recorded a marginal rise of 1.02% in consolidated earnings in the quarter ended December 2007, to Rs 1,878 million compared with Rs 1,859 million in the prior year period. The consolidated total income for the quarter climbed 7.40% to Rs 19,110 million. On standalone basis, Ranbaxy posted a substantial fall of 65.20% in earnings in the quarter ended Dec. 31, 2007, to Rs 484 million compared with Rs 1,390.70 million in the prior year period. The earnings per share (EPS) for the quarter climbed 77.21% to Re 0.85 compared with Rs 3.73 in prior year period.

Ranbaxy Q4 net profit up at Rs 301.60 cr
17th-Jan-2008
Ranbaxy has declared its fourth quarter results. Its standalone net sales at Rs 993.32 crore versus Rs 1,005.85 crore, YoY.




Source: Myiris.com, Economic Times, Indiaearnings.com. We thank (will be grateful to) the owners of the above articles/sites/sources/Govts for allowing/referring this. We are just providing the link/information of business updates from the leading sources for the benefit of readers. Viewers are strictly advised to take own decision in Stock buying and make verification about the information. Blog is not responsible for any faulty information.